The experimental drug Bremelanotide (formerly PT-141) does not act on the vascular system like the former compounds but increases sexual desire and drive in male as well as female. It is applied as a nasal spray. Bremelanotide works by activating melanocortin receptors in the brain. It is currently in Phase IIb trials. super sales of viagra online Buy viagra online canada buy viagra c.o.d viagra pills sale online order order phentermine viagra viagra online canadian pharmacy buy viagra online viagra buy to viagra where viagra for sale viagra in canada viagra pills for sale viagra sample pack check buy viagra canadian pharmacy free viagra order online viagra online canadian pharmacy online viagra viagra The study authors focused on 12 patients who had been diagnosed with chronic obstructive pulmonary disease and were suspected of having PAH. Throughout the study, right heart blood pressure was tracked among all 12 patients by inserting a thin plastic tube into the pulmonary artery -- a procedure known as cardiac catheterization. Cardiac blood pressure was measured at rest and just after all the patients cycled for three minutes. discounted viagra for sale viagra online buy viagra viagra online viagra genericviagra online Yohimbine improves erections for a small percentage of men. It stimulates the parasympathetic nervous system, which is linked to erection, and may increase libido. It is necessary to take the medication for 6 to 8 weeks before determining whether it will work or not. Second, an undescended testicle is more likely to develop a tumor. Testicular cancer affects one of every 2,000 men with undescended testicles. This rate of testicular cancer is higher than the rate in men whose testicles have dropped naturally. When the testicle is inside the scrotum, a man can easily feel his testicles to check for a tumor, or he can be checked by his doctor. This way, any tumor can be found early, when the cancer is easier to cure. Forget Viagra! Sound waves can send your sex life into orbit best price viagra viagra
 
 
Show background image
Tuesday, 2 September 2014

Cool Pictures

Shirini Yazdi

Home  >  Media  >  News Release

Overactive bladder linked to sleep apnoea in women

Sleep apnoeaVienna, Austria: Sleep apnoea in women has been linked to overactive bladder syndrome in a new study.

 

The research, presented today (3 September 2012) at the European Respiratory Society’s Annual Congress in Vienna, has provided new evidence suggesting a connection between the two conditions.

 

Overactive bladder syndrome is characterised by an increased frequency to urinate along with incontinence and frequent awakening periods during night time to use the toilet (nocturia). The need to urinate during the night is also a common symptom of sleep apnoea, but little research has been carried out to investigate any links between the two conditions.

 

Researchers from the Hospital del Mar in Barcelona, Spain, analysed 72 female patients referred to a sleep disorders clinic with suspected sleep apnoea. All patients completed a questionnaire asking them about four symptoms associated with their bladder control; urgency and frequency of urination, incontinence and nocturia. They were also asked to rate their discomfort with each of these symptoms.

 

The results from the questionnaires were then analysed and rated on two scales in order to evaluate both the severity of symptoms and discomfort for each of the four variables, scoring from 0 to 3 for each of these four items.

 

The analysis showed that 62 of the women were diagnosed with sleep apnoea. The people within this group showed significantly higher scores for the prevalence of symptoms associated with bladder control and their discomfort with these symptoms.

 

Within the group diagnosed with sleep apnoea, the symptoms were rated a median average score of 5, out of a possible total of 12, compared to a score of 3 in the group not diagnosed with the condition. The median average score for discomfort with bladder control symptoms was 4 out of 12, compared with a score of 1 in the group of women who weren’t diagnosed with sleep apnoea.

 

Lead author, Núria Grau from the Hospital del Mar in Spain, said: “Overactive bladder has a prevalence of 16% among people over 40 years in Europe and it is a difficult condition to live with, affecting a person’s quality of life. The findings of this study provide evidence that bladder control could be linked to sleep apnoea, although we do not know whether one of the conditions causes the other.

 

“The next step in our research is to investigate the role of continuous positive airway pressure therapy in these patients and its impact on the symptoms of overactive bladder.”

Notes to editors:

  • Abstract: Overactive bladder in women with sleep apnoea-hipopnea syndrome
  • Session: 233
  • Date and time: Monday 3 September, 10:45-12:45
  • Room: A1

     

Press Office at ERS Congress in Vienna (Saturday 1st September - Wednesday 5th September 2012):

Lauren Anderson: +43 6763315356   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David Sadler: +43 6767502294

Abstract Print Zone

Browse the electronic book online, print the selected pages or download the full abstract book.

Access it now